These findings demonstrate that OT+A5i has a significant ability to extend health span and highlight the sex-specific differences in aging and in responses to longevity treatments. A new study featured in the journal Aging has found that combining oxytocin with an Alk5 inhibitor (OT+A5i) can greatly improve both lifespan and healthspan in older, frail male [...]from SciTechDaily https://ift.tt/iaOVUQm
